Es­pe­ri­on un­veils long-await­ed da­ta on cho­les­terol pil­l's abil­i­ty to cut car­dio­vas­cu­lar risk: #ACC23

NEW OR­LEANS — Es­pe­ri­on Ther­a­peu­tics re­vealed long-await­ed da­ta on its heart pill’s ef­fi­ca­cy in cut­ting se­vere car­dio­vas­cu­lar out­comes, three years af­ter the drug was

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER